Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
7 Leser
Artikel bewerten:
(0)

China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F

SHENZHEN, China, May 26 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that the Company filed its annual report on Form 20-F for the year ended December 31, 2008 with the Securities and Exchange Commission on May 26, 2009. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn/ . The Company will provide a hard copy of its audited financial statements for the year ended December 31, 2008, free of charge, to its shareholders and ADS holders upon request.

About China Nepstar Chain Drugstore

China Nepstar Chain Drugstore Ltd. is China's largest retail drugstore chain based on the number of directly operated stores. As of December 31, 2008, the Company had 2,709 stores across 76 cities (including 355 stores of its Yunnan subsidiary, which ceased to be the Company's subsidiary in January 2009), one headquarters distribution center and 11 regional distribution centers in China. Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn/ .

For more information, please contact: In China: Lucia Qian China Nepstar Chain Drugstore Ltd. Marketing and IR Director Tel: +86-755-2641-4065 Email: qianrt@nepstar.cn In the United States: Dixon Chen Grayling Investor Relations Tel: +1-646-284-9403 Email: dixon.chen@us.grayling.com Ivette Almeida Grayling Media Relations Tel: +1-646-284-9455 Email: Ivette.almeida@us.grayling.com

China Nepstar Chain Drugstore Ltd.

CONTACT: In China - Lucia Qian, Marketing and IR Director, China Nepstar
Chain Drugstore Ltd. at +86-755-2641-4065 or qianrt@nepstar.cn; In the United
States - Dixon Chen, Investor Relations, Grayling at +1-646-284-9403 or
dixon.chen@us.grayling.com; Ivette Almeida, Media Relations, Grayling at
+1-646-284-9455 or Ivette.almeida@us.grayling.com

Web site: http://www.nepstar.cn/
http://ir.nepstar.cn/

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.